Combining cannabis with anabolic-androgenic steroids is not safe, and the risks go beyond what most users expect. The two substances interact at the level of liver enzymes, cardiovascular tissue, and the hormonal system in ways that can compound each other’s worst effects. Neither substance is benign on its own, and the emerging research on their combination points to cardiac damage, disrupted hormone metabolism, and unpredictable changes in how your body processes both drugs.
What “Steroids” Means Here
People searching this question almost always mean anabolic-androgenic steroids, the kind used for muscle building and performance enhancement. These are synthetic versions of testosterone and related hormones, taken as pills, injections, or topical preparations. They are distinct from corticosteroids like prednisone or hydrocortisone, which are anti-inflammatory drugs prescribed for conditions like asthma and arthritis. While corticosteroids carry their own risks when mixed with cannabis, the concerns are different. This article focuses on anabolic steroids, because that is what the bodybuilding and fitness community is asking about when the question comes up.
How Cannabis Interferes with Steroid Metabolism in the Liver
Your liver breaks down both cannabis and anabolic steroids using the same family of enzymes, particularly CYP3A4 and CYP2C9. These enzymes are workhorses of drug metabolism, responsible for processing a huge fraction of everything you swallow or inject. The problem is that THC actively interferes with these enzymes. Research on delta-8-THC found that both the parent compound and its metabolite significantly inhibited CYP2C9 and CYP3A4 activity in a dose-dependent manner, meaning the more THC present, the more these enzymes were suppressed.1PubMed Central. Inhibitory effects of Δ 8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition CBD has also been identified as a potential inhibitor of CYP3A4.2Journal of Clinical Psychopharmacology. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications
Why does this matter for someone on steroids? Many oral anabolic steroids, especially the 17-alpha-alkylated compounds like stanozolol and oxandrolone, are processed through these same CYP pathways. If THC or CBD is slowing down those enzymes, the steroid may linger in your system longer than expected, at higher concentrations. That is not a bonus. Higher-than-intended steroid levels increase the strain on your liver, your cardiovascular system, and your hormonal feedback loops. You are essentially altering the dose of both drugs without meaning to.
A 2026 study examining steroid metabolism in young male cannabis users found that several steroid metabolites showed increased concentrations among cannabis consumers, particularly hydroxylated and reduced metabolites that are normally processed by CYP enzymes. The researchers noted that while the in vitro evidence slightly favors the idea that THC and CBD inhibit CYP enzymes rather than induce them, the in vivo picture remains uncertain.3PubMed Central. Cannabis consumption is associated with altered steroid metabolism in young men The practical takeaway is that cannabis use changes how your body handles steroids at the metabolic level, and the direction of that change is difficult to predict for any individual.
Cardiovascular Damage Gets Worse When You Combine Them
The heart is where this combination looks most dangerous. Anabolic steroids are already well known to cause cardiac problems: thickening of the heart muscle, elevated blood pressure, unfavorable cholesterol shifts, and increased risk of heart attack and stroke. Cannabis, meanwhile, acutely raises heart rate and can cause blood pressure to fluctuate. Put them together, and the damage appears to multiply rather than simply add up.
A controlled study in rats examined what happens when stanozolol (a common oral anabolic steroid) and cannabis are used together, with and without exercise. The combined treatment produced serious damage to heart tissue. It drove up fibrotic markers, meaning the heart was developing scar tissue. It dramatically elevated oxidative stress markers, indicating that the heart cells were being overwhelmed by damaging molecules they could not neutralize. And it lowered glutathione, one of the body’s key built-in antioxidants, which left the heart tissue even more vulnerable.4PubMed Central. Effect of Stanozolol and/or Cannabis Abuse on Hypertrophic Mechanism and Oxidative Stress of Male Albino Rat Cardiac Tissue in Relation to Exercise: A Sport Abuse Practice
This is an animal study, so extrapolating directly to humans requires caution. But it is the most direct experimental evidence available on what happens to heart tissue when both substances are present. The findings are consistent with what cardiologists already worry about with steroid users: that the heart is under strain, and adding a second substance that affects cardiovascular function only makes things worse. Steroid users who exercise intensely, which is most of them, are already pushing their hearts harder than normal. Cannabis on top of that adds another variable the heart has to manage.
Cannabis Alters Your Hormone Profile in Ways That Work Against Steroids
People take anabolic steroids to boost testosterone and its downstream effects on muscle growth and recovery. Cannabis appears to work against that goal, at least partially. The same 2026 study that looked at steroid metabolism in young men found that cannabis consumption was associated with changes in the pattern of gonadal androgen synthesis. The researchers described a pattern suggesting that cannabinoids might selectively affect androgen production in the testes or disrupt the hormonal feedback loop that connects the brain to the gonads.3PubMed Central. Cannabis consumption is associated with altered steroid metabolism in young men
This is a subtler risk than cardiac damage, but it matters to anyone using steroids for performance. If cannabis is interfering with your body’s own testosterone production or altering how testosterone metabolites are processed, you are creating cross-purposes in your own endocrine system. The exogenous steroids are trying to push your androgen levels in one direction while the cannabis may be nudging the underlying machinery in another. The net result is harder to predict and control than either substance alone.
It is worth noting that anabolic steroids themselves already suppress natural testosterone production through feedback inhibition. Your body senses the flood of external hormones and dials down its own production. Adding cannabis as a second factor that can independently affect gonadal function means your endocrine system is being pulled in multiple directions at once. This becomes especially relevant during post-cycle therapy, when steroid users try to restart their natural hormone production after a cycle. If cannabis is still in the picture, it may complicate that recovery.
Liver Strain Adds Up Quickly
Oral anabolic steroids, particularly the 17-alpha-alkylated varieties, are famously hard on the liver. They have been linked to elevated liver enzymes, cholestasis (a backup of bile), peliosis hepatis (blood-filled cysts in the liver), and in rare cases, liver tumors. A study of steroid users found that roughly one in eight met criteria for toxicant-associated fatty liver disease, with the odds of developing this condition about six times higher than in non-users.5PubMed Central. Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease
Cannabis adds to this burden through the enzyme-inhibition pathway described earlier. When THC blocks CYP3A4 and CYP2C9, the liver has to work harder or find alternative routes to process the steroid load. The liver is not infinite in its capacity; when one metabolic pathway is congested, backup pathways may produce metabolites that are themselves more toxic. Users who are already pushing their liver with an oral steroid cycle and then smoke regularly are stacking risk on top of risk, even if each substance individually feels manageable.
Injectable steroids bypass the liver’s first-pass metabolism, which is one reason many experienced users prefer them. But even injectable steroids are eventually processed by the liver, and if cannabis is disrupting those processing enzymes, the advantage of injectable administration is partially eroded. The liver still has to clear the steroid and its metabolites, just on a different timeline.
Co-Use Is Far More Common Than People Admit
The question of smoking weed on steroids is not hypothetical for a small fringe group. Epidemiological data going back decades shows that anabolic steroid use and cannabis use are strongly correlated, especially among younger people. A study of ninth-grade students published in the New England Journal of Medicine found a significant correlation between anabolic steroid use and marijuana use, with marijuana being one of the strongest predictors of steroid use among the substances examined.6PubMed. Use of multiple drugs among adolescents who use anabolic steroids The association was not casual: marijuana use, along with shared needles, smokeless tobacco, and cocaine, accounted for about a third of the variation in steroid use in that population.
This pattern reflects something gym culture does not like to talk about openly. Steroid users are not typically single-substance users. Many use cannabis for sleep, anxiety, appetite stimulation, or pain relief, all of which become more pressing during a steroid cycle. The insomnia, irritability, and joint stress that come with heavy training on steroids make cannabis an appealing self-medication tool. But the fact that so many people do it does not make it safe. It just means the risks described above are being incurred by a large number of people who may not be aware of them.
Using One to Cope with the Other
There is a well-documented pattern of people using cannabis to manage the side effects of steroid use, and sometimes using steroids to manage the aftermath of stopping other substances. Qualitative research with women who used both anabolic steroids and psychoactive substances found that some initiated steroid use during substance abuse treatment, partly to combat the lethargy and weight gain that followed quitting drugs. One participant described starting steroids during inpatient treatment because she felt “lazy, powerless” after cessation of other substances, viewing steroids as the “boost” she needed.7Performance Enhancement & Health. Double trouble? A mixed methods study exploring experiences with combined use of anabolic-androgenic steroids and psychoactive substances among women
This self-medication cycle is a trap. Cannabis helps with the insomnia and aggression that steroids can cause, so the user keeps smoking. Steroids help with the amotivation and physical decline that follow quitting other substances, so the user keeps injecting. Each substance becomes the solution to the other’s problems, and the combined health toll keeps climbing in the background. The cardiovascular damage, the liver strain, and the hormonal disruption are all accumulating silently while the user feels like they have found a workable balance.
Blood Pressure Swings and the Unpredictability Problem
One of the trickiest aspects of combining cannabis with steroids is the unpredictable effect on blood pressure. Anabolic steroids tend to raise blood pressure through fluid retention, increased red blood cell mass, and arterial stiffening. Cannabis, on the other hand, can go either direction. Acutely, it often raises heart rate while sometimes lowering blood pressure. Research in hypertensive rats found that THC lowered blood pressure substantially in the hours after administration, and with chronic dosing, a sustained blood pressure reduction was observed compared to controls.8PubMed Central. Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands
You might think that sounds like a good thing if steroids are pushing your blood pressure up. But the reality is more chaotic. A user on steroids whose blood pressure is already elevated might smoke cannabis and experience a sudden drop, leading to dizziness, lightheadedness, or fainting, especially when standing up quickly. Or the acute heart rate increase from cannabis might combine with the already-strained cardiovascular system to trigger an arrhythmia. The problem is not that cannabis always makes blood pressure worse; it is that the interaction is unpredictable, and unpredictable cardiovascular swings in someone whose heart is already under steroid-related stress is a genuinely dangerous situation.
This is one area where heavy resistance training amplifies the risk further. Lifting heavy weights causes acute blood pressure spikes that can be extreme, sometimes exceeding 300/150 mmHg during maximal effort. Layer that on top of steroid-induced baseline elevation and cannabis-related fluctuations, and you have a cardiovascular system lurching between extremes multiple times per workout.
Why Edibles and Concentrates Change the Calculation
Most people frame this question around smoking, but the method of cannabis consumption matters for the risk profile. Smoking cannabis delivers THC rapidly but also introduces combustion byproducts that stress the lungs and cardiovascular system. Edibles deliver THC more slowly but produce higher levels of 11-hydroxy-THC, a potent metabolite formed during first-pass liver metabolism. That metabolite is one of the compounds shown to inhibit CYP2C9 and CYP3A4.1PubMed Central. Inhibitory effects of Δ 8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition So edibles may actually create a more sustained period of enzyme inhibition in the liver compared to smoking, which could mean a longer window during which steroid metabolism is disrupted.
Concentrates like dabs and vape cartridges deliver much higher doses of THC per session than flower. Higher THC exposure means more enzyme inhibition, which means a larger effect on steroid clearance. Users who have graduated from occasional joint smoking to daily concentrate use may be unknowingly amplifying the drug interaction far beyond what the early research on moderate cannabis use would suggest. The dose matters enormously, and the cannabis market has been trending toward higher and higher potency for years.
CBD-dominant products are not necessarily a safe alternative in this context. CBD is itself an inhibitor of CYP3A4, and many people who use CBD products for recovery and sleep during steroid cycles may be disrupting their steroid metabolism without realizing it.2Journal of Clinical Psychopharmacology. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications The fact that CBD does not get you high does not mean it is metabolically inert. Anyone on oral steroids who is also taking CBD oil, gummies, or topicals in meaningful doses should be aware that the same enzyme competition applies.
Timing and Cycling Considerations
Some steroid users try to manage the risk by separating their cannabis use from their steroid cycles, smoking only during off-cycle periods. This is a more thoughtful approach than daily co-use, but it has its own complications. THC is fat-soluble and can linger in body fat for weeks after the last use. During a steroid cycle that involves substantial changes in body composition, including gains in lean mass and shifts in fat distribution, stored THC metabolites may be released back into the bloodstream at unpredictable times. Whether this release is enough to cause meaningful enzyme inhibition is not well established, but it means the separation between “on cannabis” and “off cannabis” is not as clean as the separation between “on cycle” and “off cycle” for steroids.
Post-cycle therapy is another window where cannabis deserves extra caution. When users come off steroids and begin taking drugs like clomiphene or tamoxifen to restart natural testosterone production, those drugs are also metabolized by CYP enzymes. If cannabis is inhibiting those same enzymes, the recovery medications may not work as intended, potentially prolonging the period of suppressed natural hormone production. This is speculative based on the known pharmacology rather than proven in clinical trials, but it follows logically from the enzyme-inhibition data, and it is the kind of interaction that almost nobody in the bodybuilding community is tracking.
The honest state of the science is that direct human studies on the combination of anabolic steroids and cannabis are extremely limited. Most of what we know comes from animal models, in vitro enzyme studies, and observational work on cannabis users’ hormone profiles. The pieces fit together into a concerning picture, but no large clinical trial has enrolled steroid-using cannabis smokers and tracked their outcomes over years. That absence of evidence is not evidence of safety. The mechanisms of harm are well characterized, and the handful of direct studies that do exist consistently point in a worrying direction.